Literature DB >> 33171388

Discovery of allosteric binding sites by crystallographic fragment screening.

Tobias Krojer1, James S Fraser2, Frank von Delft3.   

Abstract

Understanding allosteric regulation of proteins is fundamental to our study of protein structure and function. Moreover, allosteric binding pockets have become a major target of drug discovery efforts in recent years. However, even though the function of almost every protein can be influenced by allostery, it remains a challenge to discover, rationalise and validate putative allosteric binding pockets. This review examines how the discovery and analysis of putative allosteric binding sites have been influenced by the availability of centralised facilities for crystallographic fragment screening, along with newly developed computational methods for modelling low occupancy features. We discuss the experimental parameters required for success, and how new methods could influence the field in the future. Finally, we reflect on the general problem of how to translate these findings into actual ligand development programs.
Copyright © 2020. Published by Elsevier Ltd.

Year:  2020        PMID: 33171388     DOI: 10.1016/j.sbi.2020.08.004

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  4 in total

1.  Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking.

Authors:  Marion Schuller; Galen J Correy; Stefan Gahbauer; Daren Fearon; Taiasean Wu; Roberto Efraín Díaz; Iris D Young; Luan Carvalho Martins; Dominique H Smith; Ursula Schulze-Gahmen; Tristan W Owens; Ishan Deshpande; Gregory E Merz; Aye C Thwin; Justin T Biel; Jessica K Peters; Michelle Moritz; Nadia Herrera; Huong T Kratochvil; Anthony Aimon; James M Bennett; Jose Brandao Neto; Aina E Cohen; Alexandre Dias; Alice Douangamath; Louise Dunnett; Oleg Fedorov; Matteo P Ferla; Martin Fuchs; Tyler J Gorrie-Stone; James M Holton; Michael G Johnson; Tobias Krojer; George Meigs; Ailsa J Powell; Victor L Rangel; Silvia Russi; Rachael E Skyner; Clyde A Smith; Alexei S Soares; Jennifer L Wierman; Kang Zhu; Natalia Jura; Alan Ashworth; John Irwin; Michael C Thompson; Jason E Gestwicki; Frank von Delft; Brian K Shoichet; James S Fraser; Ivan Ahel
Journal:  bioRxiv       Date:  2020-11-24

2.  Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.

Authors:  Marion Schuller; Galen J Correy; Stefan Gahbauer; Daren Fearon; Taiasean Wu; Roberto Efraín Díaz; Iris D Young; Luan Carvalho Martins; Dominique H Smith; Ursula Schulze-Gahmen; Tristan W Owens; Ishan Deshpande; Gregory E Merz; Aye C Thwin; Justin T Biel; Jessica K Peters; Michelle Moritz; Nadia Herrera; Huong T Kratochvil; Anthony Aimon; James M Bennett; Jose Brandao Neto; Aina E Cohen; Alexandre Dias; Alice Douangamath; Louise Dunnett; Oleg Fedorov; Matteo P Ferla; Martin R Fuchs; Tyler J Gorrie-Stone; James M Holton; Michael G Johnson; Tobias Krojer; George Meigs; Ailsa J Powell; Johannes Gregor Matthias Rack; Victor L Rangel; Silvia Russi; Rachael E Skyner; Clyde A Smith; Alexei S Soares; Jennifer L Wierman; Kang Zhu; Peter O'Brien; Natalia Jura; Alan Ashworth; John J Irwin; Michael C Thompson; Jason E Gestwicki; Frank von Delft; Brian K Shoichet; James S Fraser; Ivan Ahel
Journal:  Sci Adv       Date:  2021-04-14       Impact factor: 14.957

3.  Rational Design of a Novel Tubulin Inhibitor with a Unique Mechanism of Action.

Authors:  Tobias Mühlethaler; Lampros Milanos; Jose Antonio Ortega; Thorsten B Blum; Dario Gioia; Bibhas Roy; Andrea E Prota; Andrea Cavalli; Michel O Steinmetz
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-25       Impact factor: 16.823

Review 4.  Mechanism of activation and the rewired network: New drug design concepts.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Chung-Jung Tsai; Bengi Ruken Yavuz; Nurcan Tuncbag; Hyunbum Jang
Journal:  Med Res Rev       Date:  2021-10-25       Impact factor: 12.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.